Dana Bell, PhD, MS, is an RA/QA consultant specializing in the development of registration strategies and quality systems for drugs, genetically-engineered and plasma-based products. She is a part-time faculty at the USC School of Pharmacy, Department of Regulatory and Quality Sciences.
Previously, Dr. Bell was Senior Director of Global Regulatory Affairs at Baxter Healthcare Corporation. At Baxter, she was responsible for the development and the execution of regulatory strategies in the International markets for genetically-engineered and plasma-based products, drugs and devices.
She holds an MS in Pharmacy and a PhD in Biochemistry and Pharmacology. email@example.com